# A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World.

> **NCT01955681** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 200 (estimated)

## Conditions studied

- Locally Advanced or Metastatic EGFR Mutated NSCLC.

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01955681
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2015-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01955681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01955681, "A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01955681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*